ACTHREL Trademark

Trademark Overview

On Friday, September 24, 2021, a trademark application was filed for ACTHREL with the United States Patent and Trademark Office. The USPTO has given the ACTHREL trademark a serial number of 97043604. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Friday, October 10, 2025. This trademark is owned by Ferring B.V.. The ACTHREL trademark is filed in the Pharmaceutical Products category with the following description:

Hypothalmic releasing substance for use in human medicine as a diagnostic and therapeutic agent
acthrel

General Information

Serial Number97043604
Word MarkACTHREL
Filing DateFriday, September 24, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateFriday, October 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 2, 2022

Trademark Statements

Goods and ServicesHypothalmic releasing substance for use in human medicine as a diagnostic and therapeutic agent

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFerring B.V.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHoofddorp 2132JX
NL
Party NameFerring B.V.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHoofddorp 2132 JX
NL

Trademark Events

Event DateEvent Description
Tuesday, August 2, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 2, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 7, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, September 28, 2021NEW APPLICATION ENTERED
Tuesday, October 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, June 26, 2022ASSIGNED TO EXAMINER
Sunday, June 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 13, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, March 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 30, 2024SOU EXTENSION 3 FILED
Tuesday, February 7, 2023SOU EXTENSION 1 FILED
Friday, February 24, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 3, 2023SOU EXTENSION 1 GRANTED
Wednesday, September 20, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 20, 2023SOU EXTENSION 2 FILED
Wednesday, September 20, 2023SOU EXTENSION 2 GRANTED
Friday, September 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 30, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 30, 2024SOU EXTENSION 3 GRANTED
Monday, July 1, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, February 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 1, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, July 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 13, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 13, 2024SOU EXTENSION 4 FILED
Friday, October 10, 2025ABANDONMENT - NO USE STATEMENT FILED
Friday, October 10, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, July 15, 2025ASSIGNED TO EXAMINER
Tuesday, August 13, 2024SOU EXTENSION 4 GRANTED

Related Keywords

acthrel diagnostic therapeutic agent medicine human releasing substance hypothalmic